SEMAGLUTIDE : A DETAILED LOOK

The novel class of GLP-1 receptor agonist and GIP combined medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, provide significant advances in diabetes control. Despite all three work by influencing glucose readings , they distinguish in their particular mechanism